ArticleFrontiers in pharmacology2026
Age-stratified adverse-event reporting signals of seven ALK/ROS1 tyrosine kinase inhibitors in FAERS: a disproportionality and time to onset study.
Yongjian Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.